Long Acting Injectable Buprenorphine (LAIB) - Introduction
Jan 12, 2022•18 min•Season 1Ep. 22
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
An Introduction to Long Acting Injectable Buprenorphine (LAIB)
Long acting injectable buprenorphine (LAIB) are long acting buprenorphine depot preparations that are injected subcutaneously and provide patients with a sustained release of buprenorphine for the duration of the depot preparation. Currently, two LAIB products are available for the Australian market. They differ in their formulations, administration and pharmacology.
See blog for further information
https://www.meducate.com.au/blog
About Meducate ®
Meducate provides online education for doctors, clinicians, health professionals and the public.
See the website to browse the many different talks and courses availablehttps://www.meducate.com.au
For the best experience, listen in Metacast app for iOS or Android